Biomolecular condensates: new opportunities for drug discovery and RNA therapeutics
| Authors | Brooke A. Conti, Mariano Oppikofer |
|---|---|
| Details | Brooke A. Conti et al; Trends Pharmacol Sci; 2022 |
| DOI | 10.1016/j.tips.2022.07.001 |
| Topics | |
| Keywords | |
| Source |
| Authors | Brooke A. Conti, Mariano Oppikofer |
|---|---|
| Details | Brooke A. Conti et al; Trends Pharmacol Sci; 2022 |
| DOI | 10.1016/j.tips.2022.07.001 |
| Topics | |
| Keywords | |
| Source |
By taking a deep dive into the field of RNA therapeutics, our article complements the great review published by our Dewpoint colleagues in Nature Reviews Drug Discovery entitled “Modulating biomolecular condensates: a novel approach to drug discovery”.
We provide readers with forward-looking insights into a drug discovery era that integrates the evolving fields of biomolecular condensates and RNA therapeutics to deliver novel opportunities for patients.